TY - JOUR
T1 - Factors associated with buprenorphine compared to amphetamine abuse among clients seeking treatment in Finland
AU - Uosukainen, Hanna
AU - Ilomaki, Jenni Susanna
AU - Kauhanen, Jussi
AU - Tacke, Ulrich
AU - Fohr, Jaana
AU - Tiihonen, Jari
AU - Bell, John Simon Frederick
PY - 2014
Y1 - 2014
N2 - Abuse of prescription opioids is becoming increasingly widespread. This study compared the social, health and treatment-related factors associated with buprenorphine and amphetamine abuse in Finland. Structured clinical interviews were conducted with clients seeking treatment for buprenorphine (n= 670) or amphetamine (n= 557) abuse in Helsinki from January 2001 to August 2008. Unadjusted and adjusted odds ratios (ORs) with 95 confidence intervals (CIs) were computed for factors associated with buprenorphine compared to amphetamine abuse. In multivariate analyses, buprenorphine abuse was associated with male gender (OR 1.57, 95 CI 1.17-2.09), daily abuse (OR 5.45, 95 CI 4.14-7.18), no drug free months during the last year (OR 1.68, 95 CI 1.23-2.29), and inversely associated with increasing age (OR 0.95, 95 CI 0.93-0.97 per year) and psychotic symptoms (OR 0.33, 95 CI 0.24-0.45). Despite more intense abuse patterns, clients seeking treatment for buprenorphine abuse shared similar characteristics to amphetamine clients. These characteristics were different to characteristics of those who abuse prescription opioids in North America. This is important for developing and targeting intervention programs.
AB - Abuse of prescription opioids is becoming increasingly widespread. This study compared the social, health and treatment-related factors associated with buprenorphine and amphetamine abuse in Finland. Structured clinical interviews were conducted with clients seeking treatment for buprenorphine (n= 670) or amphetamine (n= 557) abuse in Helsinki from January 2001 to August 2008. Unadjusted and adjusted odds ratios (ORs) with 95 confidence intervals (CIs) were computed for factors associated with buprenorphine compared to amphetamine abuse. In multivariate analyses, buprenorphine abuse was associated with male gender (OR 1.57, 95 CI 1.17-2.09), daily abuse (OR 5.45, 95 CI 4.14-7.18), no drug free months during the last year (OR 1.68, 95 CI 1.23-2.29), and inversely associated with increasing age (OR 0.95, 95 CI 0.93-0.97 per year) and psychotic symptoms (OR 0.33, 95 CI 0.24-0.45). Despite more intense abuse patterns, clients seeking treatment for buprenorphine abuse shared similar characteristics to amphetamine clients. These characteristics were different to characteristics of those who abuse prescription opioids in North America. This is important for developing and targeting intervention programs.
UR - http://tinyurl.com/pkzl8k6
U2 - 10.1016/j.jsat.2014.01.004
DO - 10.1016/j.jsat.2014.01.004
M3 - Article
SN - 0740-5472
VL - 46
SP - 561
EP - 566
JO - Journal of Substance Abuse Treatment
JF - Journal of Substance Abuse Treatment
IS - 5
ER -